Low-molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats

27Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Fucoidan is a type of sulfated polysaccharide isolated from seaweed. The present study used ovariectomized Sprague-Dawley rats, which were treated with fucoidan. The effects of fucoidan on bone metabolism, density and microarchitecture were assessed using micro-computed tomography (CT), histomorphometric analysis, biochemical markers of bone metabolism (Serum procollagen type I N propeptide and C-terminal telopeptide-1) and tests of mechanical competence of the femur. In addition, the effects of low-molecular weight fucoidan (LMWF) on in vitro cultured osteoclasts were examined, in order to determine the mechanisms underlying LMWF-induced osteoclastic inhibition. In ovariectomized rats, LMWF increased femoral bone density. Micro-CT scan also revealed that LMWF prevented microarchitectural deterioration and histomorphometric analysis determined that LMWF increased trabecular bone number and reduced the surface of bone resorption. In addition, LMWF reduced the high bone turnover rate, and improved the mechanical properties of the femur in ovariectomized rats. In vitro experiments revealed that LMWF inhibited the receptor activator of nuclear factor κB ligand (RANKL) and macrophage colony-stimulating factor-induced differentiation of RAW264.7 cells into tartrate-resistant acid phosphatase (TRAP)-positive osteoclasts, and reduced the bone resorption surface of the osteoclasts. Reverse transcription-quantitative polymerase chain reaction demonstrated that LMWF inhibited mRNA expression of TRAP, matrix metallopeptidase-9, nuclear activator of activated T-cells 1, and osteoclast-associated immunoglobulin-like receptor, which are components of the signaling pathway for osteoclast differentiation. LMWF had no effect on RANK mRNA expression. In conclusion, the present study confirmed that LMWF inhibited osteoclast differentiation and bone resorption, and may be a potential treatment for osteoporosis in ovariectomized rats.

Author supplied keywords

References Powered by Scopus

Analysis of relative gene expression data using real-time quantitative PCR and the 2<sup>-ΔΔC</sup>T method

149910Citations
N/AReaders
Get full text

Bone resorption by osteoclasts

3356Citations
N/AReaders
Get full text

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

3019Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Biological activities of fucoidan and the factors mediating its therapeutic effects: A review of recent studies

361Citations
N/AReaders
Get full text

Marine algae polysaccharides as basis for wound dressings, drug delivery, and tissue engineering: A review

80Citations
N/AReaders
Get full text

Bioactive compounds from marine organisms: Potential for bone growth and healing

69Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Jin, X., Zhu, L., Li, X., Jia, J., Zhang, Y., Sun, X., … Ma, X. (2017). Low-molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats. Molecular Medicine Reports, 15(2), 890–898. https://doi.org/10.3892/mmr.2016.6062

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

80%

Lecturer / Post doc 1

10%

Researcher 1

10%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 4

40%

Medicine and Dentistry 3

30%

Agricultural and Biological Sciences 2

20%

Materials Science 1

10%

Save time finding and organizing research with Mendeley

Sign up for free